This trial will test a new sensor to see if it can accurately measure hydration levels in patients with sickle cell disease. The sensor could be used to help guide hydration therapy for these patients.
19 Primary · 0 Secondary · Reporting Duration: At a regularly scheduled clinical appointment, approximately 2 hours
30 Total Participants · 1 Treatment Group
Primary Treatment: Skin Hydration Sensor · No Placebo Group · N/A
Age Any Age · All Participants · 3 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: